Newsfeeds - Spark Newswire

2 minute read

Passage Bio Receives FDA Clearance Of IND Application For PBML04 For Treatment Of Metachromatic Leukodystrophy

Today, 7:54 AM

PBML04 represents the company’s fourth program to receive IND clearance PHILADELPHIA, June 08, 2022 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company focused on

PASG

1 minute read

Citigroup Maintains Buy on Passage Bio, Lowers Price Target to $10

By Benzinga Newsdesk

Today, 7:54 AM

Citigroup analyst Neena Bitritto-Garg maintains Passage Bio (NASDAQ:PASG) with a Buy and lowers the price target from $15 to $10.

PASG

1 minute read

Raymond James Maintains Outperform on Passage Bio, Lowers Price Target to $10

By Benzinga Newsdesk

Today, 7:54 AM

Raymond James analyst Danielle Brill maintains Passage Bio (NASDAQ:PASG) with a Outperform and lowers the price target from $24 to $10.

PASG

3 minute read

The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More

By Shanthi Rexaline

Today, 7:54 AM

Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from mid-cap companies.

ATNX

1 minute read

Passage Bio: Q1 Earnings Insights

By Benzinga Insights

Today, 7:54 AM

Passage Bio (NASDAQ:PASG) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

PASG

1 minute read

Passage Bio Q1 EPS $(0.79) Beats $(0.89) Estimate

By Benzinga Newsdesk

Today, 7:54 AM

Passage Bio (NASDAQ:PASG) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(0.89) by 11.24 percent. This is a 3.95 percent decrease over losses of $(0.76) per share from the

PASG

10 minute read

Earnings Scheduled For May 16, 2022

By Benzinga Insights

Today, 7:54 AM

Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.

ACRX

44 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 7:54 AM

On Wednesday, 807 companies reached new 52-week lows.

AADI

1 minute read

2 Stocks Under $3 Insiders Are Aggressively Buying

By Lisa Levin

Today, 7:54 AM

US crude oil futures traded higher on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

AWRE

2 minute read

The Daily Biotech Pulse: Limited Use Of JNJ’s COVID-19 Shot, Myovant-Pfizer’s Relugolix Application Delayed, Gain Therapeutics’ Parkinson’s Data

By Vandana Singh

Today, 7:54 AM

Here's a roundup of top developments in the biotech space over the last 24 hours.

AIM